Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.

Purpose Results of a study incorporating real-world results into a predictive model to assess the cost-effectiveness of procalcitonin (PCT)-guided antibiotic use in intensive care unit patients with sepsis are reported. Methods A single-center, retrospective cross-sectional study was conducted to de...

Full description

Bibliographic Details
Published in:American Journal of Health-System Pharmacy Vol. 76; no. 16; pp. 1219 - 1226
Main Authors: Collins, Curtis D, Brockhaus, Kara, Sim, Taeyong, Suneja, Anupam, Malani, Anurag N
Format: algorithm research tables/charts Journal Article
Published: Oxford University Press / USA Aug2019
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137893502&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137893502
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10792082
        1X3
      jtl: American Journal of Health-System Pharmacy
      issn: 10792082
      maglogo: N
    pubinfo:
      dt: Aug2019
      vid: 76
      iid: 16
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        137893502
        137893502
        137893502
        10.1093/ajhp/zxz129
        137893502
      ppf: 1219
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
      aug:
        au:
          Collins, Curtis D
          Brockhaus, Kara
          Sim, Taeyong
          Suneja, Anupam
          Malani, Anurag N
        affil: Department of Pharmacy Services, St. Joseph Mercy Health System, Ann Arbor, MI
      sug:
        subj:
          Cost Benefit Analysis
          Health Care Costs Evaluation
          Calcitonin Economics
          Antibiotics Economics
          Calcitonin Therapeutic Use
          Antibiotics Therapeutic Use
          Bacterial Infections Drug Therapy
          Bacteremia Drug Therapy
          Critically Ill Patients In Old Age
          Algorithms
          Human
          Aged
          Retrospective Design
          Cross Sectional Studies
          Treatment Duration
          Calcitonin Analysis
          Antibiotics Analysis
          Patient Admission
          Decision Making, Clinical
          Prospective Studies
          Cost Savings
          Models, Theoretical
          Quality-Adjusted Life Years
          Sex Factors
          Age Factors
          Scales
          Vasoconstrictor Agents Therapeutic Use
          Respiration, Artificial
          Quality of Life
          Aged: 65+ years
      ab: Purpose Results of a study incorporating real-world results into a predictive model to assess the cost-effectiveness of procalcitonin (PCT)-guided antibiotic use in intensive care unit patients with sepsis are reported. Methods A single-center, retrospective cross-sectional study was conducted to determine whether reductions in antibiotic therapy duration and other care improvements resulting from PCT testing and use of an associated treatment pathway offset the costs of PCT testing. Selected base-case cost outcomes in adults with sepsis admitted to a medical intensive care unit (MICU) were assessed in preintervention and postintervention cohorts using a decision analytic model. Cost-minimization and cost–utility analyses were performed from the hospital perspective with a 1-year time horizon. Secondary and univariate sensitivity analyses tested a variety of clinically relevant scenarios and the robustness of the model. Results Base-case modeling predicted that use of a PCT-guided treatment algorithm would results in hospital cost savings of $45 per patient and result in a gain of 0.0001 quality-adjusted life-year. After exclusion of patients in the postintervention cohort for PCT test ordering outside of institutional guidelines, the mean inpatient antibiotic therapy duration was significantly reduced in the postintervention group relative to the preintervention group (6.2 days versus 4.9 days, p = 0.04) after adjustment for patient sex and age, Charlson Comorbidity Index score, study period, vasopressor use, and ventilator use. Total annual hospital cost savings of $4,840 were predicted. Conclusion Real-world implementation of PCT-guided antibiotic use may have improved patients' quality of life while decreasing hospital costs in MICU patients with undifferentiated sepsis.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N